Meet our doctors Last reviewed: 19 Jun 2026 Sources Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic Patients (2020) NIH [accessed 27 January 2026] Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (2023) The Lancet [accessed 27 January 2026] How to use Mounjaro (2023) Mounjaro [accessed 27 January 2026] Lillys SURMONT-2 results published in The Lancet show tirzepatide achieve a mean weight reduction of 15.7% at the highest dose (15mg) in adults with obesity or overweight and type 2 diabetes (2023) Lillys INVESTORS [accessed 27 January 2026] MHRA authorised diabetes drug Mounjaro (tirzepatide) for weight management and weight loss (2023) GOV.UK
DOI: 10.1016/j.bcp.2018.05.003
If youre noticing muscle loss while losing weight on a GLP-1, you can take matters into your own hands by focusing on your protein intake, staying hydrated and starting a strength training program
What are common side effects of Mounjaro
We also offer in-office injections for those who live in the area, free of charge
although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries